Martin Sigl1, Klaus Amendt2, Matthias Waliszewski3,4, Nils Rathmann5. 1. First Department of Medicine, Universitätsmedizin Mannheim (UMM), Mannheim, Germany martin.sigl@umm.de. 2. Department of Angiology and Cardiology, Diakonissenkrankenhaus Mannheim, Gefäßzentrum Oberrhein, Mannheim, Germany. 3. Medical Scientific Affairs, B. Braun Melsungen AG, Berlin, Germany. 4. Department of Internal Medicine and Cardiology, Charité Universitätsmedizin, Campus Virchow, Berlin, Germany. 5. Institute of Clinical Radiology and Nuclear Medicine, Universitätsmedizin Mannheim (UMM), Mannheim, Germany.
Abstract
BACKGROUND/AIM: Restenosis and stent fractures are well-characterised treatment failures following femoropopliteal (FP) stent-based interventions. We aimed to determine patterns of restenosis and fracture rates following focal stenting of FP arteries. PATIENTS AND METHODS: This retrospective study investigated angiographic patterns of restenosis and the occurrence of stent fractures following focal FP stenting with the multiple stent delivery system VascuFlex® Multi-LOC. RESULTS: We identified 10 patients with 10 (of 129) FP lesions (mean length 11.7±4.6 cm) and a total of 51 (of 646) Multi-LOC stents that underwent clinically driven target lesion revascularizations (TLR) after 11.5±9.2 months, due to symptomatic recurrence of stenosis. None of the Multi-LOC stents had fractured. No isolated in-stent restenosis (>50%) was observed. Median diameter lumen loss was significantly more pronounced at the inter-stent segments (27.0%) compared to in-stent segments (7.8%, p=0.023). CONCLUSION: No evidence of fracture or susceptibility to stent-related restenosis using Multi-LOC stents was observed. Focal FP stenting may be more effective when combined with strategies known to reduce restenosis in non-stented artery segments. Copyright
BACKGROUND/AIM: Restenosis and stent fractures are well-characterised treatment failures following femoropopliteal (FP) stent-based interventions. We aimed to determine patterns of restenosis and fracture rates following focal stenting of FP arteries. PATIENTS AND METHODS: This retrospective study investigated angiographic patterns of restenosis and the occurrence of stent fractures following focal FP stenting with the multiple stent delivery system VascuFlex® Multi-LOC. RESULTS: We identified 10 patients with 10 (of 129) FP lesions (mean length 11.7±4.6 cm) and a total of 51 (of 646) Multi-LOC stents that underwent clinically driven target lesion revascularizations (TLR) after 11.5±9.2 months, due to symptomatic recurrence of stenosis. None of the Multi-LOC stents had fractured. No isolated in-stent restenosis (>50%) was observed. Median diameter lumen loss was significantly more pronounced at the inter-stent segments (27.0%) compared to in-stent segments (7.8%, p=0.023). CONCLUSION: No evidence of fracture or susceptibility to stent-related restenosis using Multi-LOC stents was observed. Focal FP stenting may be more effective when combined with strategies known to reduce restenosis in non-stented artery segments. Copyright
Authors: John R Laird; Barry T Katzen; Dierk Scheinert; Johannes Lammer; Jeffrey Carpenter; Maurice Buchbinder; Rajesh Dave; Gary Ansel; Alexandra Lansky; Ecaterina Cristea; Tyrone J Collins; Jeffrey Goldstein; Michael R Jaff Journal: Circ Cardiovasc Interv Date: 2010-05-18 Impact factor: 6.546
Authors: John R Laird; Thomas Zeller; Christian Loewe; Jack Chamberlin; Richard Begg; Peter A Schneider; Aravinda Nanjundappa; Frank Bunch; Scott Schultz; Stuart Harlin; Alexandra Lansky; Michael R Jaff Journal: J Endovasc Ther Date: 2017-12-29 Impact factor: 3.487
Authors: Marc Bosiers; Dierk Scheinert; Jeroen M H Hendriks; Christian Wissgott; Patrick Peeters; Thomas Zeller; Marianne Brodmann; Robert Staffa Journal: J Vasc Surg Date: 2016-04-29 Impact factor: 4.268